196 related articles for article (PubMed ID: 18056713)
1. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors.
Surinya KH; Forbes BE; Occhiodoro F; Booker GW; Francis GL; Siddle K; Wallace JC; Cosgrove LJ
J Biol Chem; 2008 Feb; 283(9):5355-63. PubMed ID: 18056713
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
Forbes BE
Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
[TBL] [Abstract][Full Text] [Related]
3. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.
Alvino CL; Ong SC; McNeil KA; Delaine C; Booker GW; Wallace JC; Forbes BE
PLoS One; 2011; 6(11):e27488. PubMed ID: 22140443
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.
Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC
J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II.
Alvino CL; McNeil KA; Ong SC; Delaine C; Booker GW; Wallace JC; Whittaker J; Forbes BE
J Biol Chem; 2009 Mar; 284(12):7656-64. PubMed ID: 19139090
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
[TBL] [Abstract][Full Text] [Related]
7. How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor.
Xu Y; Kirk NS; Venugopal H; Margetts MB; Croll TI; Sandow JJ; Webb AI; Delaine CA; Forbes BE; Lawrence MC
Structure; 2020 Jul; 28(7):786-798.e6. PubMed ID: 32459985
[TBL] [Abstract][Full Text] [Related]
8. Precise mapping of an IGF-I-binding site on the IGF-1R.
Keyhanfar M; Booker GW; Whittaker J; Wallace JC; Forbes BE
Biochem J; 2007 Jan; 401(1):269-77. PubMed ID: 16981855
[TBL] [Abstract][Full Text] [Related]
9. Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain.
Hexnerová R; Křížková K; Fábry M; Sieglová I; Kedrová K; Collinsová M; Ullrichová P; Srb P; Williams C; Crump MP; Tošner Z; Jiráček J; Veverka V; Žáková L
J Biol Chem; 2016 Sep; 291(40):21234-21245. PubMed ID: 27510031
[TBL] [Abstract][Full Text] [Related]
10. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
11. Mutations at hypothetical binding site 2 in insulin and insulin-like growth factors 1 and 2 result in receptor- and hormone-specific responses.
Macháčková K; Mlčochová K; Potalitsyn P; Hanková K; Socha O; Buděšínský M; Muždalo A; Lepšík M; Černeková M; Radosavljević J; Fábry M; Mitrová K; Chrudinová M; Lin J; Yurenko Y; Hobza P; Selicharová I; Žáková L; Jiráček J
J Biol Chem; 2019 Nov; 294(46):17371-17382. PubMed ID: 31558604
[TBL] [Abstract][Full Text] [Related]
12. Converting Insulin-like Growth Factors 1 and 2 into High-Affinity Ligands for Insulin Receptor Isoform A by the Introduction of an Evolutionarily Divergent Mutation.
Macháčková K; Chrudinová M; Radosavljević J; Potalitsyn P; Křížková K; Fábry M; Selicharová I; Collinsová M; Brzozowski AM; Žáková L; Jiráček J
Biochemistry; 2018 Apr; 57(16):2373-2382. PubMed ID: 29608283
[TBL] [Abstract][Full Text] [Related]
13. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
Hodgson DR; May FE; Westley BR
Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
[TBL] [Abstract][Full Text] [Related]
14. A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor.
Kristensen C; Andersen AS; Hach M; Wiberg FC; Schäffer L; Kjeldsen T
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):981-6. PubMed ID: 7848300
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change.
Jansson M; Hallén D; Koho H; Andersson G; Berghard L; Heidrich J; Nyberg E; Uhlén M; Kördel J; Nilsson B
J Biol Chem; 1997 Mar; 272(13):8189-97. PubMed ID: 9079636
[TBL] [Abstract][Full Text] [Related]
16. Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
Prince SN; Foulstone EJ; Zaccheo OJ; Williams C; Hassan AB
Mol Cancer Ther; 2007 Feb; 6(2):607-17. PubMed ID: 17308058
[TBL] [Abstract][Full Text] [Related]
17. Visualization of Ligand-Bound Ectodomain Assembly in the Full-Length Human IGF-1 Receptor by Cryo-EM Single-Particle Analysis.
Zhang X; Yu D; Sun J; Wu Y; Gong J; Li X; Liu L; Liu S; Liu J; Wu Y; Li D; Ma Y; Han X; Zhu Y; Wu Z; Wang Y; Ouyang Q; Wang T
Structure; 2020 May; 28(5):555-561.e4. PubMed ID: 32275863
[TBL] [Abstract][Full Text] [Related]
18. Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity.
Jansson M; Dixelius J; Uhlen M; Nilsson BO
FEBS Lett; 1997 Oct; 416(3):259-64. PubMed ID: 9373165
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
20. Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity.
Forbe BE; McNeil KA; Scott CD; Surinya KH; Cosgrove LJ; Wallace JC
Growth Factors; 2001; 19(3):163-73. PubMed ID: 11811790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
